Phthalate exposure and risk of metabolic syndrome components: A systematic review

Environ Pollut. 2024 Jan 1;340(Pt 1):122714. doi: 10.1016/j.envpol.2023.122714. Epub 2023 Oct 14.

Abstract

Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular disease, i.e. obesity, insulin resistance, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-c) levels and arterial hypertension. Phthalates are environmental chemicals which might influence the risk of the aforementioned disturbances, although the evidence is still controversial. The objective of this work was to synthesize the evidence on the association between human phthalate exposure and metabolic syndrome or any of its components. In this systematic review, the PRISMA guidelines were followed and the literature was search in PubMed, Web of Science and Scopus. Longitudinal and cross-sectional studies were included, the later only if a subclinical marker of disease was evaluated. The methodological quality was assessed with the Newcastle Ottawa Scale and a checklist for Analytical Cross-Sectional Studies developed in the Joanna Briggs Institute. A total of 58 articles were identified that showed high heterogenicity in the specific phthalates assessed, time-window of exposure and duration of follow-up. The quality of the studies was evaluated as high (n = 46, score >7 points) or medium (n = 12, score 4-6). The most frequently studied phthalates were DEHP-MEHP, MBzP and MEP. The evidence revealed a positive association between prenatal (in utero) exposure to most phthalates and markers of obesity in the offspring, but contradictory results when postnatal exposure and obesity were assessed. Moreover, postnatal phthalate exposure showed positive and very consistent associations with markers of diabetes and, to a lesser extent, with triglyceride levels. However, fewer evidence and contradictory results were found for HDL-c levels and markers of hypertension. The suggested mechanisms for these metabolic effects include transcription factor PPAR activation, antagonism of thyroid hormone function, antiandrogenic effects, oxidative stress and inflammation, and epigenetic changes. Nevertheless, as the inconsistency of some results could be related to differences in the study design, future research should aim to standardise the exposure assessment.

Keywords: Human; Metabolic syndrome; Phthalate exposure; Systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Cross-Sectional Studies
  • Environmental Exposure / adverse effects
  • Environmental Pollutants*
  • Female
  • Humans
  • Hypertension*
  • Metabolic Syndrome* / chemically induced
  • Metabolic Syndrome* / epidemiology
  • Obesity / metabolism
  • Phthalic Acids* / metabolism
  • Phthalic Acids* / toxicity
  • Pregnancy

Substances

  • Environmental Pollutants
  • phthalic acid
  • Phthalic Acids